CAR-T Therapy Target Proteins
CAR receptor molecules are genetically engineered to activate T lymphocytes and achieve an antitumour response. CAR-T therapy represents a significant advance in cancer treatment, with ongoing research into new therapeutic targets, the most common being CD19 and BCMA. These proteins are crucial for the development and effectiveness of CAR-T therapies, offering new hope for patients with certain types of cancer. At CymitQuimica, we provide a wide range of high-quality CAR-T therapy target proteins to support your research and clinical applications.
Found 446 products of "CAR-T Therapy Target Proteins"
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
| Brand | Product data | Price range | Estimated delivery |
|---|---|---|---|
 | EpCAM/TROP1 Protein, Cynomolgus/Rhesus macaque, Recombinant REF: TM-TMPK-00679 | 67,00€ ∼ 3.039,00€ | Discontinued product |
| CD4 Protein, Human, Recombinant (His & Avi), Biotinylated REF: TM-TMPY-06684 | 221,00€ ∼ 1.600,00€ | Discontinued product |
| CD19 Protein, Cynomolgus, Rhesus, Recombinant (His) REF: TM-TMPY-05420 | 608,00€ ∼ 3.832,00€ | Discontinued product |
| EGFR Protein, Human, Recombinant (Isoform vIII, aa 1-378, His) REF: TM-TMPY-06549 | 705,00€ ∼ 4.440,00€ | Discontinued product |
| GPC3 Protein-VLP, Human, Recombinant (aa 438-554) REF: TM-TMPK-00337 | 202,00€ ∼ 12.183,00€ | Discontinued product |
| TROP-2 Protein, Human, Recombinant (aa 27-274, hFc) REF: TM-TMPJ-00206 | 42,00€ ∼ 1.637,00€ | Discontinued product |